We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Genes Linked to Inflammatory Bowel Disease

By Biotechdaily staff writers
Posted on 19 Jan 2004
Researchers have pinpointed mutations in two different genes that are linked to the likelihood of developing the inflammatory bowel diseases (IBDs) ulcerative colitis and Crohn's disease.

Investigators at Johns Hopkins University (Baltimore, MD, USA) mapped DNA samples from 235 families with IBD in which 131 had offspring with ulcerative colitis for evidence of a link between the disease and the NFKB1 gene. More...
The NFKB1 gene encodes nuclear factor kappa B (NF-kappa B), a major transcription regulator of immune response, apoptosis, and cell-growth control genes. They reported in the January 1, 2004, issue of Human Molecular Genetics that one of six variants of NFKB1 was linked to increased risk of ulcerative colitis and that this deletion variant was significantly increased in the 131 ulcerative colitis offspring.

A second study, published in the December 2003 issue of the American Journal of Human Genetics, described the genetic mapping of 1,118 individuals, including 558 patients with IBD and 329 families in which at least one person had the disease. The investigators found a clear association between IBD and the MDR1 gene.

"Our greatest hope is that by identifying the gene abnormalities associated with inflammatory bowel disease, we will be able to figure out how they contribute to causing disease and then interfere with that process to stop the disease in its tracks,” said senior author Dr. Steven Brant, associate professor of medicine at Johns Hopkins University. "Taken together, these new discoveries combine with the original NOD2 gene discovery and will hopefully lead to ways to intervene and possibly prevent IBD from occurring.”



Related Links:
Johns Hopkins University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.